RG
UTHR icon

Retirement Group’s United Therapeutics UTHR Stock Holding History

Retirement Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.61K Sell
7
-1
-13% -$226 ﹤0.01% 678
2023
Q4 		$1.76K Hold
8
– – ﹤0.01% 646
2023
Q3 		$1.81K Hold
8
– – ﹤0.01% 591
2023
Q2 		$1.77K Buy
+8
New +$1.77K ﹤0.01% 627

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Retirement Group's UTHR Position: Q1 2024 in Review

Retirement Group reduced its United Therapeutics (UTHR) stake by 13% in Q1 2024, selling an estimated $226 and leaving 7 shares worth $1.61K. The position accounts for ﹤0.01% of the portfolio, ranked #678.

Retirement Group first reported a position in UTHR in Q2 2023 and has held it in 4 quarters since. The position peaked at $1.81K in Q3 2023. 526 funds tracked by Wall St. Rank hold UTHR as of Q1 2024.

  • Retirement Group held 7 shares of United Therapeutics worth $1.61K as of Q1 2024.
  • Retirement Group sold 1 United Therapeutics share in Q1 2024, an estimated $226.
  • United Therapeutics made up ﹤0.01% of Retirement Group's portfolio in Q1 2024, its #678 holding.
  • Retirement Group first reported a position in United Therapeutics in Q2 2023 and has held it in 4 quarters since.
  • Retirement Group's United Therapeutics position peaked at $1.81K in Q3 2023.
  • 526 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.